Determination of counting efficiency considering the biodistribution of 131I activity in the whole-body counting measurement

Whole-body counters are widely used to assess internal contamination after a nuclear accident. However, it is difficult to determine radioiodine activity due to limitations in conventional calibration phantoms. Inhaled or ingested radioiodine is heterogeneously distributed in the human body, necessi...

Full description

Saved in:
Bibliographic Details
Published inNuclear engineering and technology Vol. 55; no. 1; pp. 295 - 303
Main Authors Park, MinSeok, Yoo, Jaeryong, Kim, Minho, Jang, Won Il, Park, Sunhoo
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.01.2023
Elsevier
한국원자력학회
Subjects
Online AccessGet full text
ISSN1738-5733
2234-358X
DOI10.1016/j.net.2022.09.013

Cover

Loading…
More Information
Summary:Whole-body counters are widely used to assess internal contamination after a nuclear accident. However, it is difficult to determine radioiodine activity due to limitations in conventional calibration phantoms. Inhaled or ingested radioiodine is heterogeneously distributed in the human body, necessitating time-dependent biodistribution for the assessment of the internal contamination caused by the radioiodine intake. This study aims at calculating counting efficiencies considering the biodistribution of 131I in whole-body counting measurement. Monte Carlo simulations with computational human phantoms were performed to calculate the whole-body counting efficiency for a realistic radioiodine distribution after its intake. The biodistributions of 131I for different age groups were computed based on biokinetic models and applied to age- and gender-specific computational phantoms to estimate counting efficiency. After calculating the whole-body counting efficiencies, the efficiency correction factors were derived as the ratio of the counting efficiencies obtained by considering a heterogeneous biodistribution of 131I over time to those obtained using the BOMAB phantom assuming a homogeneous distribution. Based on the correction factors, the internal contamination caused by 131I can be assessed using whole-body counters. These correction factors can minimize the influence of the biodistribution of 131I in whole-body counting measurement and improve the accuracy of internal dose assessment.
ISSN:1738-5733
2234-358X
DOI:10.1016/j.net.2022.09.013